Miriam Falzon

2.1k citations
70 papers · 1.7k indexed · h-index 24
Topics
Bone health and treatments (29 papers)Pancreatitis Pathology and Treatment (8 papers)Cancer-related Molecular Pathways (8 papers)

In The Last Decade

Miriam Falzon

68 papers receiving 1.6k citations

Peers

Miriam Falzon
Comparison fields: 5 of 101
  • Molecular Biology 1.0k
  • Oncology 706
  • Genetics 197
  • Pathology and Forensic Medicine 184
  • Pulmonary and Respiratory Medicine 158
Replace Paul Thelen with:
Paul Thelen Germany
Debra A. Tonetti United States
Andrzej Semczuk Poland
Long Wang China
Petra Wilgenbus Germany
Anne‐Marie Faussat France
María U. Latasa Spain
Tsunekazu Kita Japan
Chao‐Wen Cheng Taiwan
R J Coffey United States
Miriam Falzon relative to Paul Thelen Germany Paul Thelen's profile →
Citations per field
00.5×1.5×2.3×
Paul Thelen · 1×
Citations per year

Countries citing papers authored by Miriam Falzon

Since Specialization
Citations

This map shows the geographic impact of Miriam Falzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Falzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Falzon more than expected).

Fields of papers citing papers by Miriam Falzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Falzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Falzon. The network helps show where Miriam Falzon may publish in the future.

Co-authorship network of co-authors of Miriam Falzon

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Falzon. A scholar is included among the top collaborators of Miriam Falzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Falzon. Miriam Falzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 23
2 6
3 16
4 5
5 17
6 20
7 8
8 20
9 23
10 42
11 74
12 9
13 51
14 22
15 8
16 54
17 10
18 16
19 1
20 15

About Miriam Falzon

Miriam Falzon is a scholar working on Oncology, Biochemistry and Pharmacology, having authored 70 papers that have together received 1.7k indexed citations. Recurring topics across this work include Bone health and treatments (29 papers), Pancreatitis Pathology and Treatment (8 papers) and Cancer-related Molecular Pathways (8 papers). The work is most often cited by research in Oncology (706 citations), Molecular Biology (1.0k citations) and Pharmacology (101 citations). Miriam Falzon has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Edward L. Kuff, Xiaoli Shen, Verónica A. Tovar Sepúlveda, Joseph W. Fewell, Vandanajay Bhatia, Carl W. Anderson, Nancy L. Weigel, Pingfeng Du, M.D. Burke and Hildegard M. Schuller. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026